Coppell Advisory Solutions’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
OAM
HRCM
FAM
GS
Coppell Advisory Solutions's CDNA Position: Q1 2025 in Review
Coppell Advisory Solutions sold out of CareDx (CDNA) in Q1 2025, closing a stake of 963 shares — an estimated $20.4K sold.
Coppell Advisory Solutions first reported a position in CDNA in Q3 2024 and held it in 2 quarters. The position peaked at $20.8K in Q3 2024. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.
- Coppell Advisory Solutions reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
- Coppell Advisory Solutions sold 963 CareDx shares in Q1 2025, an estimated $20.4K.
- Coppell Advisory Solutions first reported a position in CareDx in Q3 2024 and held it in 2 quarters.
- Coppell Advisory Solutions's CareDx position peaked at $20.8K in Q3 2024.
- 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.
Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.